{"schema":"hottub-news/story/v1","story":"st_3vrothd66ymdjmtc55xq","title":"Merck stops making Recarbrio, highlighting tricky landscape for new antibiotics","title_en":null,"outlets":3,"brief":null,"page":"https://hottub.news/stories/merck-stops-selling-recarbrio-in-the-u-s-leaving-hospitals-with-fewer-3vrothd66y","count":3,"items":[{"id":"n_rccnpjj5twyechhicfea","seq":1422593,"kind":"article","title":"Merck stops making Recarbrio, highlighting tricky landscape for new antibiotics","url":"https://www.healio.com/news/infectious-disease/20261002/merck-stops-making-recarbrio-highlighting-tricky-landscape-for-new-antibiotics","summary":"Merck has decided to discontinue production of a combination antibiotic used in hospitals to target life-threatening infections resistant to other medications. The drug company told Healio the decision to pull Recarbrio off the U.S. market was part of an “ongoing portfolio review” and not based on product safety or quality issues. It expected the remaining inventory to be depleted by the end of last month. “We understand that Recarbrio has been an important option for…","published":"2026-10-02T19:39:15Z","seen":"2026-10-02T20:17:22Z","lang":"en","source":{"id":"kite-healio-com-23151b","name":"healio.com","domain":"healio.com"},"via":"kite-healio-com-23151b","topics":["medicine"],"authors":["Anthony Stitt"],"entities":[{"id":"Q96472579","name":"Merck","type":"org"},{"id":"Q65648491","name":"imipenem/cilastatin/relebactam","type":"other"}],"mentions":2,"story":"st_3vrothd66ymdjmtc55xq","category":"economy-business","category_p":0.49000000953674316,"sentiment":"neutral","tone":-0.3799999952316284,"political":0.18000000715255737},{"id":"n_q6vmuplkv543pvfw7n6q","seq":1175584,"kind":"article","title":"Merck discontinues antibiotic Recarbrio in US","url":"https://www.beckershospitalreview.com/pharmacy/merck-discontinues-antibiotic-recarbrio-in-us","summary":"Merck has stopped manufacturing and marketing Recarbrio, an antibiotic that targeted multidrug-resistant infections. The FDA approved Recarbrio (cilastatin sodium, imipenem and relebactam) in July 2019 for adults with complicated urinary tract infections or complicated intra-abdominal infections who have limited or no treatment alternatives. About a year later, Recarbrio was also indicated for hospital-acquired bacterial pneumonia […] The post Merck discontinues antibiotic…","published":"2026-10-01T15:39:17Z","seen":"2026-10-01T16:28:22Z","lang":"en","country":"US","source":{"id":"kite-beckershospitalreview-com-17665f","name":"beckershospitalreview.com","domain":"beckershospitalreview.com","outlet":{"wikidata":"Q115819447","name":"Becker's Hospital Review","type":"magazine","designations":["magazine"]}},"via":"kite-beckershospitalreview-com-17665f","topics":["healthcare","usa","pharmacy"],"authors":["Paige Twenter"],"story":"st_3vrothd66ymdjmtc55xq","category":"health","category_p":0.5299999713897705,"category2":"economy-business","sentiment":"negative","tone":-0.49000000953674316,"political":0.17000000178813934},{"id":"n_3vrothd66ymdjmtc55xq","seq":1035326,"kind":"article","title":"Merck Stops Selling Recarbrio in the U.S., Leaving Hospitals with Fewer Options for Drug-Resistant Pneumonia and Infections","url":"https://www.medicaldaily.com/merck-recarbrio-discontinued-antibiotic-alternatives-patients-479314","summary":"Merck has discontinued Recarbrio, a reserve IV antibiotic for resistant hospital infections, in the U.S. Here is what patients and families should know.","published":"2026-10-01T01:19:22Z","seen":"2026-10-01T02:21:05Z","lang":"en","source":{"id":"kite-medicaldaily-com-05fda3","name":"medicaldaily.com","domain":"medicaldaily.com","outlet":{"wikidata":"Q69052919","name":"Medical Daily","type":"website","country":"US","designations":["website"]}},"via":"kite-medicaldaily-com-05fda3","topics":["medicine"],"story":"st_3vrothd66ymdjmtc55xq","category":"health","category_p":0.6700000166893005,"sentiment":"negative","tone":-0.6800000071525574,"political":0.07999999821186066}]}